组织学的临床试验
总计42334个结果
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical University主动,不招人
-
Hellenic Cooperative Oncology GroupEli Lilly and Company; Celgene Corporation完全的
-
National Health Research Institutes, TaiwanNational Taiwan University Hospital; China Medical University Hospital; Chang Gung Memorial Hospital 和其他合作者完全的
-
Leiden University Medical CenterBoehringer Ingelheim; Chordoma Foundation主动,不招人
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); EMD Serono终止
-
UNC Lineberger Comprehensive Cancer Center完全的
-
AmgenMedImmune LLC终止GI Adenocarcinoma德国, 荷兰
-
Italian Sarcoma GroupAzienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna撤销
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
University Hospital, Toulouse未知
-
University of Maryland, Baltimore完全的
-
Yale University撤销
-
University of Wisconsin, MadisonBristol-Myers Squibb; Eli Lilly and Company; Sanofi终止
-
Hoffmann-La Roche完全的一项研究 Cobimetinib 联合 Atezolizumab 和 Atezolizumab 单一疗法与瑞戈非尼在转移性结直肠腺癌参与者中的疗效和安全性的研究 (COTEZO IMblaze370)大肠癌加拿大, 美国, 意大利, 大韩民国, 英国, 比利时, 俄罗斯联邦, 香港, 西班牙, 澳大利亚, 波兰
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)终止
-
Anyang Tumor Hospital未知
-
Olympus CorporationM.D. Anderson Cancer Center; Catholic University of the Sacred Heart; Erasme University Hospital完全的